In conclusion, although hypothalamic HIF2α/HIFβ is more physiologically relevant to metabolic regulation, both HIF2α and HIF1α hold significant therapeutic potentials and can be targeted, individually or in combination, in order to counteract obesity and related metabolic diseases. This evidence concerns the gene EPAS1 and obesity due to melanocortin 4 receptor deficiency.